Intellia Therapeutics, Inc. - Multiplikator nilai perusahaan marang pendapatan NTLA

intelliatx.com (NTLA) - logo korporat

Intellia Therapeutics (NTLA) is developing CRISPR-based gene therapies to combat rare pathologies. The historical EV/Sales level demonstrates the dynamics of the business's market premium, where 20651.16 represents the most recent metric reading. The company outsources production and testing to third-party contractors while retaining patent ownership. The absence of current sales is offset by partner capital and the relevance of its technological platforms.

Intellia - Multiplikator EV/Sales NTLA (periode 23.11.2025 - 20.11.2026)

intelliatx.com - rincian analitis lan metrik utama (NTLA)

- indikator dhuwit lan arus kas:
Produk merek Intellia Therapeutics

The metric is calculated as the ratio of enterprise value (EV) to sales, excluding the impact of debt load. It determines the market premium paid for every dollar of revenue, reflecting investment expectations for future cash flows. For Intellia Therapeutics (NTLA), this indicator is driven by the high value of CRISPR patents and R&D expenditures. Strict FDA oversight makes the asset extremely sensitive to any changes. The current enterprise value-to-revenue level signals the extent of the premium for technological leadership.

Pesaing langsung

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan stoketherapeutics.com|Nilai perusahaan marang pendapatan BLFS|Nilai perusahaan marang pendapatan Wave Life Sciences Corp (WVE)|Multiplikator EV/Sales MAZE|Rasio total nilai perusahaan marang pendapatan Sionna Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Multiplikator nilai perusahaan marang pendapatan|QURE - Rasio nilai perusahaan marang pendapatan|MeiraGTx Holdings (MGTX) - Nilai perusahaan marang pendapatan|Regenxbio (RGNX) - Rasio nilai perusahaan marang pendapatan|SLDB - Rasio total nilai perusahaan marang pendapatan|OCGN (Ocugen Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PACB|Rasio nilai perusahaan marang pendapatan Benitec (BNTC)|Design Therapeutics Inc - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rocket Pharma RCKT|Multiplikator EV/Sales 4DMT FDMT|LXEO - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Korro Bio Inc.|EDIT: Multiplikator EV/Sales|SLN - Rasio total nilai perusahaan marang pendapatan|PRQR (ProQR Therapeutics) - Multiplikator EV/Sales|codexis.com (CDXS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales SGMO|Multiplikator EV/Sales Nautilus Biotechnology, Inc. (NAUT)|Multiplikator EV/Sales MGX (Metagenomi Inc.)|Nilai bisnis marang pendapatan DTIL|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan